Astria Therapeutics Inc. (ATXS)
Market Closed
23 Jan, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
12. 58
0
0%
$
718.13M Market Cap
- P/E Ratio
- Div Yield
3.06M Volume
- Eps
$ 12.58
Previous Close 
Want to track ATXS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ATXS Earnings Reports FAQ
What is the earnings per share (EPS) for ATXS?
EPS data for ATXS is currently not available, as Astria Therapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Astria Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Astria Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Astria Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ATXS at this time, as Astria Therapeutics Inc has no recent EPS data to calculate it.
